Stock Market Today 15.10.2025
BMY shines under Partha Mohanram’s P/B Growth model with an 88% rating October 15, 2025, 11:18 PM EDT. Validea’s guru fundamental report for BRISTOL-MYERS SQUIBB CO (BMY) shows the stock scoring highest
Bristol Myers Snaps Up Orbital Therapeutics in $1.5B Biotech Power Play
In-Depth Analysis BMS’s acquisition of Orbital Therapeutics marks a deliberate push into autoimmune disease treatment via advanced cell therapy. Orbital, founded in 2022 by leaders in RNA and immunology, has built a